Treatments for chronic kidney disease include hypertension control, diabetes control, lipid control, and the use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
Is it true that treatments for chronic kidney disease include hypertension control, diabetes control, lipid control, and the use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers?
Yes. Treatments for chronic kidney disease consistently involve managing hypertension, diabetes, and lipid levels alongside the use of renin-angiotensin system inhibitors such as ACE inhibitors or ARBs.
Verdict: SUPPORTED · 2 sources for, 0 against · Last checked
The retrieved papers provide strong supportive evidence that standard treatment approaches for chronic kidney disease include hypertension control, diabetes control, lipid control, and renin-angiotensin-aldosterone system inhibition (such as ACEis or ARBs). None of the papers refute this claim.
Get citation
T, N., L, H., & T, I. (2026). Preventing Cardiovascular-Kidney-Metabolic Syndrome Progression: Pharmacologic Approaches and Pharmacists' Contributions.. doi.org. https://doi.org/10.1159/000552517
See more details
Get citation
MD, A., A, V., M, Q., M, A., H, K., MF, A. J., S, M., AF, W., S, T., & M, E. (2026). Translational advances in diabetic nephropathy management: integrating nanoformulation-based drug delivery systems.. doi.org. https://doi.org/10.3389/fmedt.2026.1951734
What does the evidence say?
The retrieved papers provide strong supportive evidence that standard treatment approaches for chronic kidney disease include hypertension control, diabetes control, lipid control, and renin-angiotensin-aldosterone system inhibition (such as ACEis or ARBs). None of the papers refute this claim.
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work